Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Biotest Ag (BIESF)

Biotest Ag (BIESF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Biotest Ag

Description:

Biotest AG is a supplier of biologicamedications. The Company develops, produces and markets pharmaceuticals, as well as diagnostic and testing products and equipment for human and veterinarian applications. Its business segments include: The Therapy segment essentially combines the previous Plasma Proteins and Biotherapeutics segments. The Plasma & Services segment includes the areas of plasma sales and toll manufacturing. Other Segments is a reporting segment divided into an operationally active Merchandise business segment and a non-operational Corporate segment. Products, currently on the market and new developments are both obtained from human blood plasma and manufactured using biotechnology methods. The Company is engaged in research and development in all three of these indication areas. It covers all essential stages in the value chain, from preclinical and clinical development - which is conducted in collaboration with internationally well-known partners in the case of certain development projects - to marketing. Its products are divided between the indication areas of haematology, clinical immunology and intensive care medicine. The portfolio contains products that are already on the market and also products that are at various phases of research and clinical development. Biotest is a member of the Plasma Protein Therapeutics Association (PPT A) and has adopted the association's strict safety standards for obtaining and processing blood plasma beyond the legally prescribed requirements. According to current studies, the demand for immunoglobulins will increase by around 7 % annually in 2013 and coming years.

Key Statistics

Overview:

Annual Sales, $ 0 K
Annual Net Income, $ 0 K
Short Volume Ratio 1.00

Growth:

1-Year Return 5.91%
3-Year Return 0.00%
5-Year Return 0.00%

Per-Share Information:

Latest Earnings Date N/A
Next Ex-Dividends Date 05/08/14
Dividend Payable Date 05/08/14
Dividend Payout Ratio 0.00%

BIESF Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % N/A
Return-on-Assets % N/A
Profit Margin % 0.00%
Debt/Equity N/A
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share N/A
Interest Coverage N/A
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar